With this acquisition, GE appears to make a big investment in the DNA market....they have a multitude of products, mostly for lab testing and filtering on one hand...but also have some products related directly to storage and transport of DNA...and one product will allow for faster DNA data mining...BD
GE Healthcare, a unit of General Electric Company (NYSE:GE) announced that it has completed the acquisition of Whatman Plc, a global supplier of filtration products and technologies.
The acquisition expands GE Healthcare's offering for life science research and biopharmaceutical manufacturing, a key area of growth for the company. GE Healthcare's Life Sciences business is a world-class provider of technologies for cellular and protein science research, and tools used in the manufacture of biopharmaceuticals such as vaccines, cell therapies and antibodies.
"In order to meet and anticipate the unique needs of our customers, Whatman is organized into three business development units: LabSciences, which focuses on the preparation of non-cellular samples prior to analysis; BioScience, which focuses on the preparation of cellular samples prior to analysis and storage for study of nucleic acids or proteins; and MedTech, which focuses on filtration components for manufacturers of medical devices and clinical diagnostic tests. "
Plasmid DNA can be eluted or used directly on a punch to transform bacteria either by electroporation or heat-shock methods.
0 comments :
Post a Comment